TY  - GEN
AU  - Berenguer-Daizé,Caroline
AU  - Astorgues-Xerri,Lucile
AU  - Odore,Elodie
AU  - Cayol,Mylène
AU  - Cvitkovic,Esteban
AU  - Noel,Kay
AU  - Bekradda,Mohamed
AU  - MacKenzie,Sarah
AU  - Rezai,Keyvan
AU  - Lokiec,François
AU  - Riveiro,Maria E
AU  - Ouafik,L'Houcine
TI  - OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
SN  - 1097-0215
PY  - 2017///0501
KW  - Acetanilides
KW  - administration & dosage
KW  - Animals
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Blood-Brain Barrier
KW  - drug effects
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Camptothecin
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Dacarbazine
KW  - Drug Synergism
KW  - Everolimus
KW  - Gene Expression Regulation, Neoplastic
KW  - Glioblastoma
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Irinotecan
KW  - Mice
KW  - Temozolomide
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/ijc.30256
ER  -